AIDS Healthcare Foundation (AHF) praised today the head of the World Trade Organization, Dr. Ngozi Okonjo Iweala, for calling on developing countries to put in place legal mechanisms to suspend …
AHF Applauds Novel Gonorrhea Treatment
AIDS Healthcare Foundation (AHF) applauds promising clinical trial results for a new drug zoliflodacin, which was co-developed by Swiss nonprofit Global Antibiotic Research & Development Partnership and U.S.-based company Innoviva Specialty …
AHF Urges Affordable Access to New Dengue Drug
The AIDS Healthcare Foundation (AHF) commends Johnson & Johnson (J&J) for developing a pill that has shown promising results in a small trial for protecting against dengue fever and urges …
Patients Suffer as Pfizer Pockets Profits
The AIDS Healthcare Foundation (AHF) rebuked pharmaceutical giant Pfizer today for announcing that it plans to charge $1,400 for a five-day course of the COVID-19 antiviral drug Paxlovid. During the pandemic, the U.S. government …
Africa Needs Vaccines to Fight Mpox, Wealthy Countries Must Act
With a deadly endemic mpox (formerly monkeypox) strain ravaging parts of Africa, particularly the Democratic Republic of the Congo, due to little-to-no vaccine access on the continent, AIDS Healthcare Foundation (AHF) urges the Global North to …
AHF Praises Colombia’s Stand for Accessible HIV Treatment
AIDS Healthcare Foundation (AHF) supports and applauds the Colombian government’s decision to utilize a compulsory license to import cheaper generic versions of ViiV Healthcare’s HIV treatment dolutegravir. The country spends …
Newly Approved Malaria Vaccine Is a Win for Global Health
AIDS Healthcare Foundation (AHF) applauds the World Health Organization’s (WHO) recommendation of a new malaria vaccine, R21/Matrix-M, for preventing malaria, which disproportionately affects African children. The affordable and easily deployable vaccine is a …
J&J Patent Move Must be First of Many
AIDS Healthcare Foundation (AHF) acknowledged today pharmaceutical company Johnson & Johnson’s (J&J) announcement that it will not enforce its patent for the multi-drug resistant tuberculosis treatment SIRTURO (bedaquiline) for 134 …
Disappointment and Hope after U.N. General Assembly Wraps
The weeklong 78th U.N. General Assembly concluded today in New York City with the adoption of declarations on pandemic prevention, preparedness, and response (PPPR), tuberculosis (TB), and universal health coverage …
